Analysed GLAUKOS CORP (GKOS:NYSE) News Sources
Glaukos to Release First Quarter 2026 Financial Results after Market Close on April 29
08-04-2026
yahoo.com
Does Glaukos (GKOS) Using Epioxa at ASCRS Hint at a Broader Corneal-Health Strategy Shift?
07-04-2026
yahoo.com
Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
06-04-2026
yahoo.com
Glaukos Announces Commercial Availability of Epioxa™, a Transformative Innovation in Interventional Keratoconus Care
19-03-2026
yahoo.com
Should Glaukos’ (GKOS) Big 2026 Sales Target and ESOP Shelf Filing Require Action From Investors?
26-02-2026
yahoo.com
What is the current price of GLAUKOS CORP (GKOS:NYSE)?
The current price of GLAUKOS CORP (GKOS:NYSE) is $118.44.
GLAUKOS CORP (GKOS:NYSE) absolute price change since previous trading day?
The absolute price change of GLAUKOS CORP (GKOS:NYSE) since the previous trading day is $2.04.
GLAUKOS CORP (GKOS:NYSE) percentage price change since previous trading day?
The percentage price change of GLAUKOS CORP (GKOS:NYSE) since the previous trading day is 1.7526%.
What is the most recent average sentiment score for GLAUKOS CORP (GKOS:NYSE)?
The most recent average sentiment score for GLAUKOS CORP (GKOS:NYSE) is 69 out of 100.
What is the most recent average sentiment for GLAUKOS CORP (GKOS:NYSE)?
The most recent sentiment for GLAUKOS CORP (GKOS:NYSE) is .
SEC-8K** Filing Available For GLAUKOS CORP (GKOS:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.